Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Tenet Health (THC)

Tenet Q4 net income rises to $318 million as revenue falls 5.7% to $5.07 billion

Mixed Impact 3 of 5 earnings Written later

Tenet Healthcare reported fourth quarter 2024 results and issued its full year 2025 outlook. Fourth quarter net income available to common shareholders rose to $318 million, or $3.32 per diluted share, from $244 million, or $2.30, a year earlier, while net operating revenues fell 5.7% to $5.072 billion, reflecting hospital divestitures.

Key points

  • Q4 2024 adjusted diluted EPS was $3.44, versus $2.68 in Q4 2023
  • Q4 2024 Adjusted EBITDA was $1.048 billion, versus $1.012 billion in Q4 2023
  • FY 2025 Adjusted EBITDA outlook is $3.975 billion to $4.175 billion, with net operating revenues of $20.6 billion to $21.0 billion

The filing

CompanyTenet Health (THC)
Form8-K, current report
Filed with the SECFeb 12, 2025, 6:47 AM ET
Accession number0000070318-25-000005

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:42 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 12, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.